ArticlePharmaceutical research2008

Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth.

Kyeongsoon Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.